| 000 | 01918 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518021925.0 | ||
| 264 | 0 | _c20190705 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1532-2653 | ||
| 024 | 7 |
_a10.1016/j.jocn.2019.01.022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWoo, Peter Y M | |
| 245 | 0 | 0 |
_aDetermining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study. _h[electronic resource] |
| 260 |
_bJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia _cMay 2019 |
||
| 300 |
_a134-141 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aChemoradiotherapy, Adjuvant |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlioblastoma _xdiagnostic imaging |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aKarnofsky Performance Status |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm, Residual _xdiagnosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aTemozolomide _xtherapeutic use |
| 650 | 0 | 4 | _aTumor Burden |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aHo, Jason M K | |
| 700 | 1 | _aTse, Teresa P K | |
| 700 | 1 | _aLam, Sandy W | |
| 700 | 1 | _aMak, Calvin H K | |
| 700 | 1 | _aChan, Danny T M | |
| 700 | 1 | _aLee, Michael W Y | |
| 700 | 1 | _aWong, Sui-To | |
| 700 | 1 | _aChan, Kwong-Yau | |
| 700 | 1 | _aPoon, Wai-Sang | |
| 773 | 0 |
_tJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia _gvol. 63 _gp. 134-141 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jocn.2019.01.022 _zAvailable from publisher's website |
| 999 |
_c29322518 _d29322518 |
||